<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03992157</url>
  </required_header>
  <id_info>
    <org_study_id>2016-38</org_study_id>
    <nct_id>NCT03992157</nct_id>
  </id_info>
  <brief_title>Evaluation of Ambulatory ECG Telemetry for the Early Detection of Atrial Fibrillation During Hospital Assessment of Cerebral Infarction</brief_title>
  <acronym>TELEMETRIE</acronym>
  <official_title>Evaluation of Ambulatory ECG Telemetry for the Early Detection of Atrial Fibrillation During Hospital Assessment of Cerebral Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital Foch</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hopital Foch</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to show that an ambulatory ECG telemetry monitoring of some patients
      hospitalized for cerebral infarction increases the frequency of the diagnosis of atrial
      fibrillation, cause of their stroke, and reinforces the protection against recurrences.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Medical practices have evolved and are not conform with the study procedure. Actually, all
    patients receive an ambulatory ECG telemetry monitoring
  </why_stopped>
  <start_date type="Actual">December 27, 2018</start_date>
  <completion_date type="Actual">July 3, 2019</completion_date>
  <primary_completion_date type="Actual">July 3, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic impact of outpatient ECG telemetry</measure>
    <time_frame>6 months</time_frame>
    <description>Percentage of patients hospitalized for cerebral infarction and with a diagnosis of atrial fibrillation allowed by the use of ambulatory ECG telemetry.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Identification of prognostic factors to identify de novo atrial fibrillation</measure>
    <time_frame>6 months</time_frame>
    <description>Retrospective evaluation of prognostic criteria (clinical data, biomarkers, abdominal MRI) in patients with a diagnosis of AF</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate the therapeutic impact (prescription anticoagulant) at the end of hospitalisation</measure>
    <time_frame>6 months</time_frame>
    <description>Percentage of patients on anticoagulation at the end of hospitalisation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate the benefit on the recurrence rate of cerebral infarction after the exit of the service</measure>
    <time_frame>3 months</time_frame>
    <description>Percentage of IC recurrence in the department and within 3 months of the IC diagnosis</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">8</enrollment>
  <condition>Cerebral Infarction</condition>
  <arm_group>
    <arm_group_label>holter-ECG</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Implementation of an ECG Holter during hospitalisation patient.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Crontrole</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No implementation of an ECG Holter</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ECG telemetry</intervention_name>
    <description>ECG telemetry (holter ECG) is a portable case - attached to the belt or around the neck - connected to 6 electrodes placed on the skin next to the heart. They are worn by patients during their stay in hospital</description>
    <arm_group_label>holter-ECG</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients over 18 years old

          -  Diagnosis of transient ischemic or cerebral accident

          -  Absence of etiological orientation after the initial assessment (including at least
             cerebral MRI, angiography of the supra aortic trunks by CT or MRI, echocardiography
             with search for patent foramen ovale, standard biology)

          -  Affiliated to a social security system.

          -  Having given no opposition to participation in research

        Exclusion Criteria:

          -  AF known or diagnosed during stay in USINV
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bertrand Lapergue, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hopital Foch</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hopital Foch</name>
      <address>
        <city>Suresnes</city>
        <zip>92150</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>June 18, 2019</study_first_submitted>
  <study_first_submitted_qc>June 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 20, 2019</study_first_posted>
  <last_update_submitted>December 30, 2019</last_update_submitted>
  <last_update_submitted_qc>December 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>stroke</keyword>
  <keyword>ECG</keyword>
  <keyword>telemetry</keyword>
  <keyword>atrial fibrillation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cerebral Infarction</mesh_term>
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

